David Meek, Mirati CEO (Marlene Awaad/Bloomberg via Getty Images)
Mirati gauging sale interest of Big Pharmas — report
Mirati Therapeutics, maker of the experimental cancer drug adagrasib, is piquing the interest of Big Pharmas, according to a report from Bloomberg.
On Tuesday, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.